CH625526A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625526A5 CH625526A5 CH784176A CH784176A CH625526A5 CH 625526 A5 CH625526 A5 CH 625526A5 CH 784176 A CH784176 A CH 784176A CH 784176 A CH784176 A CH 784176A CH 625526 A5 CH625526 A5 CH 625526A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- group
- alkyl
- compound
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB26188/75A GB1555471A (en) | 1975-06-19 | 1975-06-19 | 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CH625526A5 true CH625526A5 (fr) | 1981-09-30 |
Family
ID=10239713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH784176A CH625526A5 (fr) | 1975-06-19 | 1976-06-18 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4074047A (fr) |
JP (1) | JPS5214793A (fr) |
AT (1) | AT353956B (fr) |
AU (1) | AU505041B2 (fr) |
BE (1) | BE843152A (fr) |
CH (1) | CH625526A5 (fr) |
DE (1) | DE2627212A1 (fr) |
DK (1) | DK272676A (fr) |
ES (1) | ES449032A1 (fr) |
FR (1) | FR2315933A1 (fr) |
GB (1) | GB1555471A (fr) |
NL (1) | NL7606614A (fr) |
SE (1) | SE7607037L (fr) |
ZA (1) | ZA763635B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5517823B2 (fr) * | 1972-05-16 | 1980-05-14 | ||
JPS4986668A (fr) * | 1972-12-27 | 1974-08-20 | ||
US4175185A (en) * | 1976-05-19 | 1979-11-20 | Meiji Seika Kaisha Ltd. | Process for preparing cephalosporanic acid derivatives |
GB1591439A (en) * | 1976-10-01 | 1981-06-24 | Glaxo Operations Ltd | 7-syn (oxyimino -acylamido) cephalosporins |
US4208517A (en) * | 1976-11-30 | 1980-06-17 | Glaxo Operations Uk Limited | Caphalosporin compounds having at position-7 an α-etherified hydroxyiminoarylacetamido group |
GB1596278A (en) * | 1976-11-30 | 1981-08-26 | Glaxo Operations Ltd | 7-(-oxyimino-acetamino)cephalosporin derivatives |
NL7805715A (nl) * | 1977-06-03 | 1978-12-05 | Hoffmann La Roche | Werkwijze voor het bereiden van acylderivaten. |
DE2967356D1 (en) * | 1978-07-17 | 1985-02-28 | Fujisawa Pharmaceutical Co | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
NO782998L (no) * | 1978-07-19 | 1980-01-22 | Hoffmann La Roche | Cephalosporinestere og -etere. |
US4284631A (en) * | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
US4198504A (en) * | 1978-11-02 | 1980-04-15 | Bristol-Myers Company | [3-(Pyridinium)-7-(naphthyiridinyl carbonylamino)acetamido]cephalosporanic acid derivatives |
US4337376A (en) * | 1979-12-31 | 1982-06-29 | Broadcom, Incorporated | Communications system and network |
US7427680B2 (en) * | 2001-01-12 | 2008-09-23 | The Regents Of The University Of California | Fluorogenic substrates for BETA-lactamase gene expression |
EP1711504A2 (fr) | 2004-01-21 | 2006-10-18 | Molecular Probes Inc. | Derives de cephalosporin et de l'acide clavulanique pour detecter beta-lactamase dans un echantillon |
CN114478149B (zh) * | 2022-01-18 | 2023-09-15 | 吉林化工学院 | 一种羧酸类化合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
US3971778A (en) * | 1972-05-12 | 1976-07-27 | Glaxo Laboratories Limited | Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position |
GB1453049A (en) * | 1973-08-21 | 1976-10-20 | Glaxo Lab Ltd | Cephalosporing antibiotics |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
DE2262500A1 (de) * | 1972-12-20 | 1973-07-05 | Lilly Co Eli | 3-oxyiminomethylcephalosporinverbindungen |
DK674674A (fr) * | 1973-12-21 | 1975-09-08 | Glaxo Lab Ltd |
-
1975
- 1975-06-19 GB GB26188/75A patent/GB1555471A/en not_active Expired
-
1976
- 1976-06-09 US US05/694,465 patent/US4074047A/en not_active Expired - Lifetime
- 1976-06-18 AT AT445876A patent/AT353956B/de not_active IP Right Cessation
- 1976-06-18 SE SE7607037A patent/SE7607037L/xx unknown
- 1976-06-18 ES ES449032A patent/ES449032A1/es not_active Expired
- 1976-06-18 AU AU15032/76A patent/AU505041B2/en not_active Expired
- 1976-06-18 NL NL7606614A patent/NL7606614A/xx not_active Application Discontinuation
- 1976-06-18 CH CH784176A patent/CH625526A5/de not_active IP Right Cessation
- 1976-06-18 JP JP51072692A patent/JPS5214793A/ja active Pending
- 1976-06-18 DK DK272676A patent/DK272676A/da not_active Application Discontinuation
- 1976-06-18 BE BE168099A patent/BE843152A/fr not_active IP Right Cessation
- 1976-06-18 FR FR7618662A patent/FR2315933A1/fr active Granted
- 1976-06-18 ZA ZA763635A patent/ZA763635B/xx unknown
- 1976-06-18 DE DE19762627212 patent/DE2627212A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NL7606614A (nl) | 1976-12-21 |
DK272676A (da) | 1976-12-20 |
AU505041B2 (en) | 1979-11-08 |
DE2627212A1 (de) | 1977-01-13 |
FR2315933B1 (fr) | 1979-10-12 |
JPS5214793A (en) | 1977-02-03 |
SE7607037L (sv) | 1976-12-20 |
ES449032A1 (es) | 1977-11-16 |
ZA763635B (en) | 1977-05-25 |
GB1555471A (en) | 1979-11-14 |
BE843152A (fr) | 1976-12-20 |
AU1503276A (en) | 1977-12-22 |
ATA445876A (de) | 1979-05-15 |
AT353956B (de) | 1979-12-10 |
US4074047A (en) | 1978-02-14 |
FR2315933A1 (fr) | 1977-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2223375A1 (de) | Antibiotika und Verfahren zu ihrer Herstellung | |
CH625526A5 (fr) | ||
DE2744135A1 (de) | Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
DE2204060A1 (de) | Cephalosporin- und Penicillin-Antibiotika | |
DE2432415A1 (de) | Antibiotica | |
DE2439880A1 (de) | Antibiotika und verfahren zu ihrer herstellung | |
CH648851A5 (de) | Cephalosporinantibiotika, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE2460537C2 (de) | 7-β-Acylamido-3-em-4-carbonsäure-Antibiotika | |
EP0009008A2 (fr) | Dérivés de céphalosporine, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
CH647784A5 (de) | Cephalosporinantibiotika. | |
EP0163190A2 (fr) | Bêta-lactam antibiotiques, procédé pour leur préparation et leur utilisation comme médicaments ou comme stimulants de la croissance dans l'élevage d'animaux ou comme anti-oxydants | |
CH626370A5 (en) | Process for the preparation of the syn isomer or of a mixture of syn and anti isomers of 7beta-acylamidoceph-3-em-4-carboxylic acids with antibiotic activity | |
US4385177A (en) | Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position | |
EP0000500B1 (fr) | Dérivés de, cephalosporine leur préparation et leurs compositions pharmaceutiques | |
EP0000392A2 (fr) | Céphalosporines et pénicillines, procédés pour leur préparation et leurs compositions pharmaceutiques | |
CH649557A5 (de) | Cephalosporinantibiotika. | |
DE3011038A1 (de) | Cephalosporinantibiotika | |
EP0035161B1 (fr) | Céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
DE2943437A1 (de) | Cephalosporinverbindungen | |
DE69033952T2 (de) | Antibakterielle Cephalosporin-Derivate | |
DE3341591C2 (fr) | ||
EP0054677B1 (fr) | Céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
AT362500B (de) | Verfahren zur herstellung von neuen cephalos- porin-antibiotika | |
AT367061B (de) | Verfahren zur herstellung von neuen antibiotischen verbindungen | |
EP0053276A2 (fr) | Céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |